Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SAGE-324 for essential tremor has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• SAGE-324 (SAGE-324)

Snippet

Sponsor: Sage Therapeutics | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2024-04-17